Last $48.26 USD
Change Today +0.49 / 1.03%
Volume 6.7M
ALB On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

albemarle corp (ALB) Snapshot

Open
$47.03
Previous Close
$47.77
Day High
$48.83
Day Low
$46.78
52 Week High
07/15/14 - $76.28
52 Week Low
01/30/15 - $46.78
Market Cap
5.4B
Average Volume 10 Days
3.3M
EPS TTM
$2.99
Shares Outstanding
112.5M
EX-Date
12/11/14
P/E TM
16.1x
Dividend
$1.10
Dividend Yield
2.28%
Current Stock Chart for ALBEMARLE CORP (ALB)

albemarle corp (ALB) Related Businessweek News

No Related Businessweek News Found

albemarle corp (ALB) Details

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals. It provides brominated and mineral based flame retardants under the Saytex, Martinal, and Magnifin brands that are used in plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, and foam insulation; and plastic and other additives, such as curatives, antioxidants, and stabilizers under the Ethacure and Ethanox brands. The company also offers refinery catalysts, including hydroprocessing catalysts, fluidized catalytic cracking catalysts, and additives; organometallic co-catalysts and metallocene components and co-catalysts; electronic materials, such as high purity metal organic products, as well as other products; and chemical catalysts used in the chemical industry, as well as provides single-site catalysts and Ziegler-Natta catalysts under the Advantage brand. In addition, the company provides elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications, as well as tertiary amines for surfactants, biocides, disinfectants, and sanitizers; and aluminum oxides for use in various refractory, ceramic and polishing applications. Further, it supplies fine chemistry products and performance chemicals for pharmaceutical and agricultural use, as well as provides custom manufacturing, research, and chemical scale-up services for companies. The company serves petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety, and custom chemistry service markets. Albemarle Corporation was founded in 1993 and is headquartered in Baton Rouge, Louisiana.

6,900 Employees
Last Reported Date: 01/28/15
Founded in 1993

albemarle corp (ALB) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $800.0K
Chief Financial Officer, Chief Risk Officer a...
Total Annual Compensation: $443.8K
Senior Vice President and President of Cataly...
Total Annual Compensation: $106.6K
Senior Vice President, General Counsel of Cor...
Total Annual Compensation: $397.0K
Senior Vice President of Human Resources
Total Annual Compensation: $406.0K
Compensation as of Fiscal Year 2013.

albemarle corp (ALB) Key Developments

Albemarle Corporation Announces Successful Completion of Consent Solicitation for Rockwood Notes

Albemarle Corporation announced the successful completion of the previously announced consent solicitation relating to the 4.625% Senior Notes due 2020 which were issued by Rockwood Specialties Group Inc. and are guaranteed by Albemarle. On January 28, 2015 (the "Expiration Date"), the companies had received consents from holders of a majority in principal amount of the outstanding Notes to the adoption of certain proposed amendments to the indenture governing the Notes. As a result, the Company entered into the Third Supplemental Indenture to effectuate such amendments. The consent solicitation was made pursuant to the consent solicitation statement dated January 20, 2015. The companies will make a cash payment of $2.50 per $1,000 principal amount of Notes to each holder of Notes who validly delivered a consent prior to the Expiration Date.

Albemarle Seeks To Pursue Strategic Alternatives For Non-Core Businesses

Albemarle Corporation (NYSE:ALB) will pursue strategic alternatives for three businesses, namely minerals, fine chemistry services and metal. Albemarle believes selling the non-core businesses represents the "optimal choice" for maximizing value.

Albemarle Corporation Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Albemarle Corporation announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. The company reported a fourth quarter 2014 net loss attributable of $18.5 million, or $0.24 per share, compared to fourth quarter 2013 net income attributable to company of $155.9 million, or $1.91 per share. Fourth quarter 2014 adjusted earnings were $77.4 million, or $0.99 per share, compared to $89.3 million, or $1.09 per share, for the fourth quarter of 2013. The Company reported net sales of $598.6 million in the fourth quarter of 2014, down from net sales of $639.6 million in the fourth quarter of 2013, driven mainly by unfavorable currency exchange and pricing impacts across all the businesses, and lower volumes in Performance Chemicals. Operating loss was $23.338 million against operating profit of $227.110 million a year ago. Net loss from continuing operations was $12.990 million or $0.22 per diluted share against net income from continuing operations of $162.232 million or $1.92 per diluted share a year ago. LBITDA was $5.335 million against EBITDA of $254.456 million a year ago. Adjusted EBITDA was $136.833 million against $145.042 million a year ago. Net income attributable to company for the full year 2014 were $133.3 million, or $1.69 per share, compared to $413.2 million, or $4.90 per share, for the full year 2013. Adjusted earnings for the full year 2014 were $332.1 million, or $4.20 per share, compared to $338.2 million, or $4.01 per share, for the full year 2013. Net sales for the full year 2014 were $2.45 billion, up from $2.39 billion for the full year 2013, driven mainly by favorable Catalyst Solutions pricing and volumes on strong demand, partly offset by lower volumes and pricing in Performance Chemicals and the unfavorable effects of currency exchange. Operating profit was $271.298 million against operating profit of $576.675 million a year ago. Net income from continuing operations was $230.437 million or $2.57 per diluted share against net income from continuing operations of $435.726 million or $4.85 per diluted share a year ago. Capital expenditures were $110.576 million against $155.346 million a year ago. EBITDA was $275.822 million against EBITDA of $688.422 million a year ago. Adjusted EBITDA was $562.155 million against $557.551 million a year ago. Cash flow from operations was approximately $459.2 million for the year ended December 31, 2014, up 6% against the same period in 2013 on lower working capital.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALB:US $48.26 USD +0.49

ALB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,657 GBp -49.00
Cytec Industries Inc $47.99 USD +0.59
Kyowa Hakko Kirin Co Ltd ¥1,348 JPY +12.00
Lonza Group AG SFr.109.20 CHF +2.70
WR Grace & Co $86.68 USD +1.67
View Industry Companies
 

Industry Analysis

ALB

Industry Average

Valuation ALB Industry Range
Price/Earnings 18.8x
Price/Sales 1.5x
Price/Book 2.8x
Price/Cash Flow 40.7x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBEMARLE CORP, please visit www.albemarle.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.